Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02340455
Other study ID # 4-2014-0907
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date December 2014
Est. completion date December 2016

Study information

Verified date February 2019
Source Yonsei University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hyperalgesia is known to be caused by the excitatory amino acid through NMDA receptor. GABA, an inhibitory amino acid, alters the opioid receptor sensitivity against pain resulting hyperalgesia. If the GABA level can be maintained at certain level, the progression into hyperalgesia can be averted. GABA related drugs are known to decrease the postoperative opioid consumption, lower the degree of pain, and prevent hyperalgesia. We hypothesize the effective postoperative pain management and the prevention of hyperalgesia from pregabalin, GABA analogue, and the possible sex difference in such effects of pregabalin.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date December 2016
Est. primary completion date November 2016
Accepts healthy volunteers No
Gender All
Age group 19 Years to 50 Years
Eligibility Inclusion Criteria:

- 18, <51 years

- healthy patients accepted for video-assisted living donor nephrectomy

Exclusion Criteria:

- Female patients who are pregnant or menopause

- Patients undergoing hormonal therapy

- Patients having neurologic disease or already taking GABA related drugs (pregabalin, gabapentin), or taking opioid drugs

- Insulin resistant diabetes

- Renal deficiency (eGFR < 60 ml/min/1.73 m2)

- Emergency operation, hemodynamically unstable patients

- Foreigner

- allergic to medication given in this study

Study Design


Related Conditions & MeSH terms

  • Living Kidney Donors Undergoing VAMS-nephrectomy

Intervention

Drug:
Pregabalin_male
Pregabalin 150mg bid 1day Men
Pregabalin_female
Pregabalin 150mg bid 1day Women
Placebo_Men
Placebo durg
Placebo_Women
Placebo_Women

Locations

Country Name City State
Korea, Republic of Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mechanical threshold Mechanical threshold can be measured using von Frey filaments at both incision site and non-dominant arm from 1 day before op to postop 48 hr